Nov 30 (Reuters) - Altamira Therapeutics Ltd:
* ALTAMIRA THERAPEUTICS ANNOUNCES LAUNCH OF BENTRIO IN HONG KONG BY ITS PARTNER NUANCE PHARMA
* ALTAMIRA THERAPEUTICS LTD - NUANCE PHARMA TO FILE FOR MARKETING APPROVAL IN MACAO, MAINLAND CHINA AND SOUTH KOREA IN 2023
* ALTAMIRA THERAPEUTICS LTD - UPON REACHING CERTAIN MILESTONES, NUANCE WILL ASSUME LOCAL PRODUCTION OF BENTRIO FOR ITS LICENSED TERRITORY
* ALTAMIRA THERAPEUTICS - UPON REACHING CERTAIN MILESTONES, NUANCE WILL PAY TO CO A STAGGERED ROYALTY AT A HIGH-SINGLE TO LOW-DOUBLE DIGIT PERCENTAGE Source text for Eikon: Further company coverage: